• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美沙酮、丁丙诺啡与 α2 肾上腺素能激动剂用于阿片类药物脱毒治疗的比较:混合治疗比较荟萃分析。

A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.

机构信息

CORE, University College London, Research Department of Clinical, Educational and Health Psychology, London WC1E 7HB, UK.

出版信息

Drug Alcohol Depend. 2010 Apr 1;108(1-2):110-4. doi: 10.1016/j.drugalcdep.2009.12.008. Epub 2010 Jan 13.

DOI:10.1016/j.drugalcdep.2009.12.008
PMID:20074867
Abstract

OBJECTIVES

The aim of this systematic review was to compare the efficacy of methadone, buprenorphine, clonidine and lofexidine for opioid detoxification. Mixed treatment comparison meta-analyses were used to synthesise the data as it is designed for data-sets where limitations in standard pairwise meta-analyses make comparisons difficult to interpret.

DATA SOURCES

A systematic search was conducted using the following databases: CENTRAL, CINAHL, Embase, HMIC, Medline and PsycINFO.

REVIEW METHODS

RCTs that included opioid dependent participants over a mean age of 16 receiving opioid detoxification using buprenorphine, methadone, clonidine or lofexidine were included in the systematic review. Included studies were quality assessed and the completion of treatment data was extracted by the author and a research assistant independently. Mixed treatment comparison methods were used to synthesise the data.

RESULTS

There were 23 RCTs included in the systematic review (and 20 included in the meta-analysis) comprising a total of 2112 participants. Buprenorphine and methadone were ranked as the most effective methods of opioid detoxification followed by lofexidine and clonidine respectively.

CONCLUSION

Buprenorpine and methadone appear to be the most effective detoxification treatments. While the analysis suggests buprenorphine is the most effective method of detoxification there is some uncertainty on whether it is more effective than methadone and requires further research to confirm this result.

摘要

目的

本系统评价旨在比较美沙酮、丁丙诺啡、可乐定和洛非西定在阿片类药物戒毒中的疗效。混合治疗比较荟萃分析用于综合数据,因为它是为数据集中存在标准成对荟萃分析难以解释的局限性而设计的。

资料来源

使用以下数据库进行了系统搜索:CENTRAL、CINAHL、Embase、HMIC、Medline 和 PsycINFO。

审查方法

包括年龄在 16 岁以上的阿片类药物依赖参与者在内的 RCT,使用丁丙诺啡、美沙酮、可乐定或洛非西定进行阿片类药物戒毒的研究被纳入系统评价。纳入的研究进行了质量评估,作者和一名研究助理独立提取完成治疗的数据。使用混合治疗比较方法综合数据。

结果

系统评价包括 23 项 RCT(Meta 分析中包括 20 项),共纳入 2112 名参与者。丁丙诺啡和美沙酮被评为阿片类药物戒毒最有效的方法,其次是洛非西定和可乐定。

结论

丁丙诺啡和美沙酮似乎是最有效的戒毒治疗方法。虽然分析表明丁丙诺啡是最有效的戒毒方法,但尚不确定它是否比美沙酮更有效,需要进一步研究来证实这一结果。

相似文献

1
A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.美沙酮、丁丙诺啡与 α2 肾上腺素能激动剂用于阿片类药物脱毒治疗的比较:混合治疗比较荟萃分析。
Drug Alcohol Depend. 2010 Apr 1;108(1-2):110-4. doi: 10.1016/j.drugalcdep.2009.12.008. Epub 2010 Jan 13.
2
Buprenorphine for managing opioid withdrawal.丁丙诺啡用于管理阿片类药物戒断。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.
3
Opioid antagonists with minimal sedation for opioid withdrawal.用于阿片类药物戒断且镇静作用极小的阿片类拮抗剂。
Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4.
4
Alpha2 adrenergic agonists for the management of opioid withdrawal.用于管理阿片类药物戒断的α2肾上腺素能激动剂。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002024. doi: 10.1002/14651858.CD002024.pub2.
5
Buprenorphine for the management of opioid withdrawal.丁丙诺啡用于阿片类物质戒断的管理。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002025. doi: 10.1002/14651858.CD002025.pub2.
6
Alpha₂-adrenergic agonists for the management of opioid withdrawal.用于管理阿片类药物戒断的α₂肾上腺素能激动剂。
Cochrane Database Syst Rev. 2016 May 3;2016(5):CD002024. doi: 10.1002/14651858.CD002024.pub5.
7
Buprenorphine for the management of opioid withdrawal.丁丙诺啡用于阿片类物质戒断的管理。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD002025. doi: 10.1002/14651858.CD002025.pub4.
8
Opioid antagonists and adrenergic agonists for the management of opioid withdrawal.用于管理阿片类药物戒断的阿片类拮抗剂和肾上腺素能激动剂。
Cochrane Database Syst Rev. 2000(2):CD002021. doi: 10.1002/14651858.CD002021.
9
Pharmacological therapies for management of opium withdrawal.用于鸦片戒断管理的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 21;6(6):CD007522. doi: 10.1002/14651858.CD007522.pub2.
10
Alpha2 adrenergic agonists for the management of opioid withdrawal.用于管理阿片类药物戒断的α2肾上腺素能激动剂。
Cochrane Database Syst Rev. 2003(2):CD002024. doi: 10.1002/14651858.CD002024.

引用本文的文献

1
Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis.在退伍军人健康管理局初级保健中实施丁丙诺啡治疗阿片类药物使用障碍:一项定性分析。
Addict Sci Clin Pract. 2025 Apr 30;20(1):38. doi: 10.1186/s13722-025-00568-9.
2
At a Crossroads: Opioid Use Disorder, the X-Waiver, and the Road Ahead.处于十字路口:阿片类物质使用障碍、X豁免权及未来之路
Ochsner J. 2024 Summer;24(2):108-117. doi: 10.31486/toj.23.0074.
3
A Retrospective Comparison of the Effectiveness of Buprenorphine Versus Baclofen for Acute Opioid Withdrawal.
丁丙诺啡与巴氯芬治疗急性阿片类药物戒断效果的回顾性比较
HCA Healthc J Med. 2023 Apr 28;4(2):139-149. doi: 10.36518/2689-0216.1498. eCollection 2023.
4
Opium Addiction: Practical Issues in ICU.阿片类药物成瘾:重症监护病房中的实际问题
Indian J Crit Care Med. 2021 Sep;25(9):1082-1083. doi: 10.5005/jp-journals-10071-23939.
5
Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.改善美国退伍军人医疗保健系统中非成瘾诊所处方行为的干预措施后,阿片类药物使用障碍药物的可及性。
JAMA Netw Open. 2021 Dec 1;4(12):e2137238. doi: 10.1001/jamanetworkopen.2021.37238.
6
Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities.临床领导人和提供者对在退伍军人事务部设施中提供治疗阿片类药物使用障碍的药物的看法。
Addict Sci Clin Pract. 2021 Sep 6;16(1):55. doi: 10.1186/s13722-021-00263-5.
7
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats.美沙酮、丁丙诺啡和可乐定可减轻大鼠米托蒽醌戒断反应。
Front Pharmacol. 2021 Jul 12;12:708019. doi: 10.3389/fphar.2021.708019. eCollection 2021.
8
A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms.洛非西定治疗阿片类戒断症状的全面更新。
Psychopharmacol Bull. 2020 Jul 23;50(3):76-96.
9
Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases.超越抗生素:传染病医生在合并感染性疾病情况下治疗阿片类物质使用障碍的实用指南。
Open Forum Infect Dis. 2019 Dec 24;7(1):ofz539. doi: 10.1093/ofid/ofz539. eCollection 2020 Jan.
10
Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.VA 住院治疗项目中实施阿片类药物使用障碍药物治疗的障碍和促进因素。
J Stud Alcohol Drugs. 2018 Nov;79(6):909-917. doi: 10.15288/jsad.2018.79.909.